Medical Transcription Billing Revenue, Profits - MTBC Quarterly Income Statement

Add to My Stocks
$4.39 $0 (0%) MTBC stock closing price Aug 13, 2018 (Closing)

Fundamental analysis of MTBC stock involves analyzing its financial statements, apart from checking the Medical Transcription Billing stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 8.31M to 8.68M and how operating and non operating activities have impacted the MTBC stock. One also needs to look at Medical Transcription Billing assets, operating expenses and Medical Transcription Billing free cash flow. The Medical Transcription Billing profit and loss statement shows revenue of $8.68M for 2018 Q2. Revenue has grown by 4.45% QoQ for MTBC stock.

View and download details of revenue and profits for Medical Transcription Billing for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Medical Transcription Billing Revenues or Net Sales
Cost Of Goods Sold (COGS)4.33M4.48M4.09M4.17M4.19M5.22M6.12M2.67M2.32M2.3M
Medical Transcription Billing Gross Profit
Research & Development Expense----------
Selling General & Admin Expense3.47M2.93M3.77M2.7M3.2M3.6M4.58M2.64M2.54M3.2M
Income Before Depreciation Depletion Amortization------0.89M-2.18M-0.15M--0.59M
Depreciation Depletion Amortization----1.45M1.51M1.58M1.11M1.2M1.21M
Non Operating Income---------0.01M-
Interest Expense----------
Medical Transcription Billing Pretax Income
Provision for Income Taxes---0.12M-------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations---0.18M-0.98M-1.69M-2.71M-4.02M-1.5M-1.29M-1.98M
Extraordinary Items & Discontinued Operations----------
Medical Transcription Billing Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS11.67M11.62M13.3M11.49M10.83M10.17M10.04M10.01M10M10.09M
Average Shares used to compute Basic EPS11.67M11.62M13.3M11.49M10.83M10.17M10.04M10.01M10M10.09M
Income Before Nonrecurring Items----0.45M-0.16M-0.98M-2.37M-1.5M-1.29M-0.71M
Income from Nonrecurring Items--0.46M-0.33M-0.54M-1.54M-1.73M-1.65M---1.28M
Medical Transcription Billing Earnings Per Share Basic Net
Medical Transcription Billing Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-
Preferred Dividends Acc Pd1.24M---------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on Medical Transcription Billing stock analysis. An investor must check the following items in an income statement:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Medical Transcription Billing revenue chart, implies that the company is growing. It has been the case with Medical Transcription Billing. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $- for Medical Transcription Billing for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The MTBC financials along with Medical Transcription Billing historical stock prices provide a lot of details about the firm.

Medical Transcription Billing Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Operating Margin
Net Profit Margin
Dividend Yield